Chengliang Yang

1.9k total citations
76 papers, 1.3k citations indexed

About

Chengliang Yang is a scholar working on Surgery, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Chengliang Yang has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 15 papers in Molecular Biology and 12 papers in Infectious Diseases. Recurrent topics in Chengliang Yang's work include COVID-19 Clinical Research Studies (8 papers), Additive Manufacturing and 3D Printing Technologies (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Chengliang Yang is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Additive Manufacturing and 3D Printing Technologies (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Chengliang Yang collaborates with scholars based in China, Canada and Australia. Chengliang Yang's co-authors include Yu Liu, Yegang Ma, Yixue Xue, Scott J. Tebbutt, Yongyu Liu, Mingyao Liu, Yujin Tang, Yao Li, Yufei Lu and Zhen Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Chengliang Yang

73 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengliang Yang China 20 480 192 186 177 155 76 1.3k
Feiqiu Wen China 20 509 1.1× 219 1.1× 153 0.8× 157 0.9× 78 0.5× 117 1.4k
Amparo Ruiz‐Saurí Spain 26 565 1.2× 176 0.9× 145 0.8× 115 0.6× 331 2.1× 85 2.2k
Zhengdong Zhang China 18 439 0.9× 156 0.8× 157 0.8× 100 0.6× 139 0.9× 52 1.0k
Lei Chu China 21 363 0.8× 108 0.6× 199 1.1× 70 0.4× 101 0.7× 90 1.4k
Renata Ferreira de Carvalho Leitão Brazil 23 420 0.9× 94 0.5× 151 0.8× 257 1.5× 167 1.1× 75 1.7k
Weihua Xu China 23 705 1.5× 427 2.2× 191 1.0× 212 1.2× 435 2.8× 84 1.8k
Jianguo Liu China 23 460 1.0× 193 1.0× 245 1.3× 243 1.4× 360 2.3× 101 1.8k
Chun Liu China 19 437 0.9× 124 0.6× 255 1.4× 150 0.8× 234 1.5× 87 1.4k
Weiwei Liu China 18 541 1.1× 188 1.0× 146 0.8× 145 0.8× 192 1.2× 48 1.2k
Jianpeng Gao China 14 424 0.9× 174 0.9× 141 0.8× 99 0.6× 140 0.9× 50 984

Countries citing papers authored by Chengliang Yang

Since Specialization
Citations

This map shows the geographic impact of Chengliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengliang Yang more than expected).

Fields of papers citing papers by Chengliang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengliang Yang. The network helps show where Chengliang Yang may publish in the future.

Co-authorship network of co-authors of Chengliang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengliang Yang. A scholar is included among the top collaborators of Chengliang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengliang Yang. Chengliang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Chengliang, Alain Amstutz, Matthias Briel, et al.. (2025). Cardiac adverse events associated with remdesivir in COVID-19 patients: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 15(7). e089977–e089977. 1 indexed citations
2.
3.
Zhang, Fan, Shokouh Attarilar, Chao Han, et al.. (2021). Carfilzomib alleviated osteoporosis by targeting PSME1/2 to activate Wnt/β-catenin signaling. Molecular and Cellular Endocrinology. 540. 111520–111520. 10 indexed citations
4.
Ruan, Guangfeng, Chengliang Yang, Tao Meng, et al.. (2021). Associations between diet quality and knee joint structures, symptoms and systemic abnormalities in people with symptomatic knee osteoarthritis. Clinical Nutrition. 40(5). 2483–2490. 7 indexed citations
5.
Liu, Xiaomei, et al.. (2020). The toxicity effects of nano/microplastics on an antibiotic producing strain - Streptomyces coelicolor M145. The Science of The Total Environment. 764. 142804–142804. 55 indexed citations
6.
Yang, Chengliang, Shaf Keshavjee, & Mingyao Liu. (2020). Alpha-1 Antitrypsin for COVID-19 Treatment: Dual Role in Antiviral Infection and Anti-Inflammation. Frontiers in Pharmacology. 11. 615398–615398. 36 indexed citations
7.
Liu, Jia, Shokouh Attarilar, Chong Wang, et al.. (2020). Nano-Modified Titanium Implant Materials: A Way Toward Improved Antibacterial Properties. Frontiers in Bioengineering and Biotechnology. 8. 576969–576969. 92 indexed citations
8.
9.
Yang, Chengliang, Sining Shen, Xiaoli Zheng, et al.. (2019). Long noncoding RNA HAGLR acts as a microRNA‐143‐5p sponge to regulate epithelial‐mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3. The FASEB Journal. 33(9). 10490–10504. 45 indexed citations
10.
Tang, Yujin, Kai Li, Chengliang Yang, et al.. (2019). <p>Bisperoxovanadium protects against spinal cord injury by regulating autophagy via activation of ERK1/2 signaling</p>. Drug Design Development and Therapy. Volume 13. 513–521. 9 indexed citations
11.
Yang, Chengliang, Xiaoli Zheng, Ke Ye, et al.. (2018). NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. The International Journal of Biochemistry & Cell Biology. 99. 43–51. 20 indexed citations
12.
Yang, Chengliang, Xiaoli Zheng, Ke Ye, et al.. (2018). MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1. Cellular Physiology and Biochemistry. 46(1). 93–106. 37 indexed citations
13.
Yang, Chengliang, et al.. (2017). Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA). Medicine. 96(7). e6097–e6097. 17 indexed citations
14.
Deng, Hongkuan, et al.. (2016). Identification and functional analysis of invasion associated locus B (IalB) in Bartonella species. Microbial Pathogenesis. 98. 171–177. 15 indexed citations
15.
Liu, Xinli, Nan Sun, Yinan Dong, et al.. (2015). Anticancer effects of adenovirus-mediated calreticulin and melanoma-associated antigen 3 expression on non-small cell lung cancer cells. International Immunopharmacology. 25(2). 416–424. 7 indexed citations
16.
Yang, Chengliang, et al.. (2015). Antitumor effect of recombinant human endostatin combined with cisplatin on rats with transplanted Lewis lung cancer. Asian Pacific Journal of Tropical Medicine. 8(8). 664–667. 3 indexed citations
17.
Sun, Yanan, Yufei Lu, Wei Guo, et al.. (2014). Interfractional Variations of Tumor Centroid Position and Tumor Regression during Stereotactic Body Radiotherapy for Lung Tumor. BioMed Research International. 2014. 1–8. 5 indexed citations
18.
Zhang, Liang, Chengliang Yang, Yue Leon Guo, et al.. (2014). Wogonoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice. Inflammation. 37(6). 2006–2012. 33 indexed citations
19.
Pan, Wen, et al.. (2013). Peripheral blood CD40–CD40L expression in human breast cancer. Irish Journal of Medical Science (1971 -). 182(4). 719–721. 9 indexed citations
20.
Yang, Chengliang, Yegang Ma, Yixue Xue, et al.. (2011). Curcumin Induces Small Cell Lung Cancer NCI-H446 Cell Apoptosis via the Reactive Oxygen Species-Mediated Mitochondrial Pathway and Not the Cell Death Receptor Pathway. DNA and Cell Biology. 31(2). 139–150. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feiqiu Wen Breakdown of academic impact, for papers by Amparo Ruiz‐Saurí Breakdown of academic impact, for papers by Zhengdong Zhang Breakdown of academic impact, for papers by Lei Chu Breakdown of academic impact, for papers by Renata Ferreira de Carvalho Leitão Breakdown of academic impact, for papers by Weihua Xu Breakdown of academic impact, for papers by Jianguo Liu Breakdown of academic impact, for papers by Chun Liu Breakdown of academic impact, for papers by Weiwei Liu Breakdown of academic impact, for papers by Jianpeng Gao
Rankless by CCL
2026